Written by Prabha Raghavan, edited by Explained Desk | New Delhi | Updated: September 11, 2020 6:23:32 pm An employee is treated at the Special Immunobiological Reference Center (CRIE) of the Federal University of Sao Paulo (Unifesp) where the Oxford / AstraZeneca coronavirus vaccine trials were being carried out, in …
Read More »
The world’s largest vaccine maker, the Serum Institute of India, has decided to stop trials of the Covid-19 vaccine in the country in the wake of AstraZeneca stopping it after an unexplained illness to a participant. IBS has partnered with biopharmaceutical company AstraZeneca to manufacture the experimental Covid-19 candidate vaccine …
Read More »
LONDON: A woman who received an experimental coronavirus vaccine developed severe neurological symptoms that led to a pause in testing, a spokesman for the pharmaceutical company AstraZeneca said on Thursday. The study participant in the late-stage trials reported symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, …
Read More »
LONDON: A woman who received an experimental coronavirus vaccine developed severe neurological symptoms that led to a pause in testing, a spokesman for the pharmaceutical company AstraZeneca said on Thursday. The study participant in the late-stage trials reported symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, …
Read More »
In this illustration, taken on April 10, 2020, small vials labeled with a “COVID-19 Vaccine” label and a medical syringe are seen (REUTERS / Dado Ruvic / Illustration / File photo). The Serum Institute of India halted trials of the Covid-19 vaccine in India one day after AstraZeneca halted trials …
Read More »
A staff member places a Sinovac Biotech Ltd coronavirus vaccine candidate on its booth for display during the 2020 China International Trade in Services Fair (CIFTIS), following the COVID-19 outbreak, in Beijing, China, on September 5, 2020. REUTERS / Tingshu Wang UN Secretary General Antonio Guterres urged countries to find …
Read More »
LONDON: AstraZeneca CEO Pascal Soriot on Wednesday expressed his hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company will be ready by the end of 2020 or early 2021, despite having to pause clinical trials. Earlier this week, the Swedish-British company froze the trials after discovering …
Read More »
LONDON: AstraZeneca CEO Pascal Soriot on Wednesday expressed his hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company will be ready by the end of 2020 or early 2021, despite having to pause clinical trials. Earlier this week, the Swedish-British company froze the trials after discovering …
Read More »
A day after the Serum Institute of India (SII) received a demonstration cause notice from the Controller General of Drugs of India (DCGI), it said it was pausing trials of the Covid-19 vaccine in the country. IBS is manufacturing the Covishield vaccine at the University of Oxford in collaboration with …
Read More »
The Serum Institute of India said on Thursday it was halting the University of Oxford-Astrazeneca’s COVID-19 vaccine trial in India until the British-Swedish drugmaker restarts the trial. The move came a day after the Pune-based vaccine maker received a notice of demonstration cause from the Drugs General Inspector of India …
Read More »